New inhaled treatment tested for cystic fibrosis lung function
Disease control
Completed
This study tested a new inhaled medication called ETD001 for people with cystic fibrosis. The first part checked if the medication was safe to take for a week. The second part measured whether taking it twice daily for 28 days could improve how well the lungs work, compared to a …
Phase: PHASE2 • Sponsor: Enterprise Therapeutics Ltd • Aim: Disease control
Last updated Mar 31, 2026 12:10 UTC